The biggest fish—which I assume are the ones you are going to be most worried about from a GCR perspective—are very likely to self-insure.
I’m also less confident in insurers’ abilities to insist on and monitor risk from AI development than risk exposure from application of AI. For instance, it seems a lot easier for a third party (who knows much less about AI systems than the insured) to figure out “You shouldn’t let AI determine the results of that CT scan without a human overread” than “You shouldn’t use technique X to grow your AI technology.”
The biggest fish—which I assume are the ones you are going to be most worried about from a GCR perspective—are very likely to self-insure.
I’m also less confident in insurers’ abilities to insist on and monitor risk from AI development than risk exposure from application of AI. For instance, it seems a lot easier for a third party (who knows much less about AI systems than the insured) to figure out “You shouldn’t let AI determine the results of that CT scan without a human overread” than “You shouldn’t use technique X to grow your AI technology.”